Construction of an Immunogenomic Risk Score for Prognostication in Colon Cancer

• Published in: Frontiers in genetics 2020-05, Vol.11, p.499-499
• Main Authors: Zhang, Han, Qin, Chuan, Gan, Hua, Guo, Xiong, Zhang, Li
• Format: Article
• Language: English
• Subjects: biomarkers; colon cancer; Genetics; immune system; immune-related genes; prognostication
• ISSN: 1664-8021; 1664-8021
• DOI: 10.3389/fgene.2020.00499

Immune-related genes (IRGs) play regulatory roles in the immune system and are involved in the initiation and progression of colon cancer. This study aimed to develop an immunogenomic risk score for predicting survival outcomes among colon cancer patients. We analyzed the expressions of IRGs in colon specimens and discovered 484 differentially expressed IRGs when we compared specimens from colon cancer and adjacent normal tissue. Univariate Cox regression analyses were performed to identify 26 IRGs that were associated with survival. A Cox proportional hazards model with a lasso penalty identified five optimal IRGs for constructing the immunogenomic risk score ( CD1B, XCL1, PLCG2, NGF , and OXTR ). The risk score had good performance in predicting overall survival among patients with colon cancer and was correlated with the amount of tumor-infiltrating immune cells. Our findings suggest that the immunogenomic risk score may be useful for prognostication in colon cancer cases. Furthermore, the five IRGs included in the risk score might be useful targets for investigating the initiation of colon cancer and designing personalized treatments.